CGON logo

CG Oncology, Inc. (CGON) Shareholders Equity

Annual Shareholders Equity:

$733.38M+$548.59M(+296.87%)
December 31, 2024

Summary

  • As of today, CGON annual stockholders equity is $733.38 million, with the most recent change of +$548.59 million (+296.87%) on December 31, 2024.
  • During the last 3 years, CGON annual shareholders equity has risen by +$693.13 million (+1721.96%).
  • CGON annual shareholders equity is now at all-time high.

Performance

CGON Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONbalance sheet metrics

Quarterly Shareholders Equity:

$670.36M-$34.40M(-4.88%)
June 30, 2025

Summary

  • As of today, CGON quarterly stockholders equity is $670.36 million, with the most recent change of -$34.40 million (-4.88%) on June 30, 2025.
  • Over the past year, CGON quarterly shareholders equity has increased by +$118.00 million (+21.36%).
  • CGON quarterly shareholders equity is now -8.59% below its all-time high of $733.38 million, reached on December 31, 2024.

Performance

CGON Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

CGON Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+296.9%+21.4%
3Y3 Years+1722.0%+435.5%
5Y5 Years+1722.0%+435.5%

CGON Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+1722.0%-8.6%+435.5%
5Y5-Yearat high+1722.0%-8.6%+435.5%
All-TimeAll-Timeat high+1722.0%-8.6%+435.5%

CGON Shareholders Equity History

DateAnnualQuarterly
Jun 2025
-
$670.36M(-4.9%)
Mar 2025
-
$704.76M(-3.9%)
Dec 2024
$733.38M
$733.38M(+36.6%)
Sep 2024
-
$536.77M(-2.8%)
Jun 2024
-
$552.36M(-2.9%)
DateAnnualQuarterly
Mar 2024
-
$568.94M(+207.9%)
Dec 2023
$184.79M(+47.6%)
$184.79M(+47.6%)
Dec 2022
$125.18M(+211.0%)
-
Dec 2022
-
$125.18M
Dec 2021
$40.25M
-

FAQ

  • What is CG Oncology, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual shareholders equity year-on-year change?
  • What is CG Oncology, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly shareholders equity year-on-year change?

What is CG Oncology, Inc. annual stockholders equity?

The current annual shareholders equity of CGON is $733.38M

What is the all-time high annual shareholders equity for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual stockholders equity is $733.38M

What is CG Oncology, Inc. annual shareholders equity year-on-year change?

Over the past year, CGON annual stockholders equity has changed by +$548.59M (+296.87%)

What is CG Oncology, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of CGON is $670.36M

What is the all-time high quarterly shareholders equity for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly stockholders equity is $733.38M

What is CG Oncology, Inc. quarterly shareholders equity year-on-year change?

Over the past year, CGON quarterly stockholders equity has changed by +$118.00M (+21.36%)
On this page